Drug · DIN 02470276
REBINYN
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 23, 2018; first marketed March 23, 2018.
- Drug Identification Number (DIN)
- 02470276
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor ix B02BD04
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED | 2000 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 29, 2017: NOC 20100New Drug Submission (NDS)
Other DINs named REBINYN
- DIN 02470187 · Marketed
- DIN 02470268 · Marketed
- DIN 02532964 · Marketed